Linking Neuroscience and Behavior in Covid-19

Herausgeber: Rajendram, Rajkumar; R Martin, Colin; Patel, Vinood; Preedy, Victor R

• Gebundenes Buch

Produktbeschreibung

Linking Neuroscience and Behavior in COVID-19 examines the effect of both the virus and the pandemic on behavior and mental health. Chapters look at the burden of the COVID-19 pandemic on those with pre-existing conditions, including Parkinson's disease and multiple sclerosis. The ongoing consequences of the pandemic on the mental health of the broad populace are discussed. As well as the neurological effects of the virus itself, chapters discuss psychological concerns including depression and anxiety. Finally, the chapters also include aspects relevant to managing care and the treatment of conditions. A broad range of conditions preceding, caused by, or emerging for the first time during the pandemic are also detailed.

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Verlag: Elsevier Science
• Seitenzahl: 630
• Erscheinungstermin: 30. Juli 2024
• Englisch
• Gewicht: 1960g
• ISBN-13: 9780323956505
• ISBN-10: 0323956505
• Artikelnr.: 69767531

Inhaltsangabe

Preface
Section A: Introductory chapters and setting the scene
1. The historical aspects of the SARS-CoV-2 virus and the ensuing pandemic
2. Different variants of SARS-CoV-2
3. Lateral flow assay for SARS-CoV-2 infection: Uses and limitations
4. Linking community participation, mobility disabilities, and the COVID-19
pandemic
5. Influence of the sources used to obtain information on COVID-19 and
their impact on mental health
Section B: Impact on behavior and psychology
6. The psychological experiences and distress of defined populations in the
COVID-19 pandemic: Doctors
7. Impact of COVID-19 on behavior in autism spectrum disorder
8. Prepandemic stressors in mental health responses to the COVID-19
pandemic: Early life adversities and beyond
9. Compulsive hoarding in the COVID-19 pandemic
10. The psychological experiences and distress in Japan and Sweden during
the COVID-19 pandemic
11. The COVID-19 pandemic, mental health, and sleep: Linking depression,
anxiety, and perceived
stress
12. The Covid-19 pandemic and the occupational overload of health
professionals: Indicators of
burnout
13. Neurocognitive sequelae of SARS-CoV-2 infection: Pathogenesis, risk
factors, assessment, and implications
14. Acute neurocognitive disorder as a presenting manifestation of COVID-19
15. Mental health and the impact of confinement
16. Cannabis use in the COVID-19 pandemic: Changes in different populations
and implications
for policy
17. Impact of COVID-19 on mental health in women: Socioeconomic groups and
global aspects
18. Quality of life assessment of patients after COVID-19
19. COVID-19 pandemic and remote working: Toward a new way of working
20. Long COVID and its persistence: A focus on mental health
21. The impact of the COVID-19 pandemic on behavioral and psychological
features of vulnerable groups: Patients with multiple sclerosis and their
quality of life
Section C: Effects on neurological structures and mechanisms
23. Linking pediatric COVID-19 with basal ganglia and dentate nucleus
24. Sensory disorders, neuroinflammation, and COVID-19
25. The effects of COVID-19 isolations on nonmotor features of Parkinson's
disease
26. Myelitis following COVID-19: The road so far
27. The corpus callosum: Effects due to SARS-CoV-2 infection and the mRNA
vaccine
28. Assessing the impact of prenatal SARS-CoV-2 exposure on infants'
neurodevelopment: A comprehensive analysis of current evidence
29. Electroencephalographic features with COVID-19
30. Survivors of COVID-19 and clinical neuropsychological domain
characteristics
31. Neuroinflammation following SARS-CoV-2 infection
32. Functional magnetic resonance imaging and depressive symptoms in
subjects with COVID-19
33. Impact of COVID-19 on the brain: Antibodies against brain stem antigens
34. The kynurenine pathway and role in mental health of post-COVID-19
patients
Section D: Management, support and treatments
35. Management of brain tumors in the COVID-19 pandemic
36. The impact of the COVID-19 pandemic on ischemic stroke management: From
hyperacute to chronic phase
37. Long COVID and the potential use of palmitoylethanolamide
38. Cognitive assessments in post-COVID syndrome: A focus on the
neuropsychological tests and
protocols
39. Supporting individuals with intellectual and developmental disabilities
during the COVID-19
pandemic
40. Preserving well-being and quality of life through school-based
interventions focused on physical
activity during the COVID-19 pandemic
41. Hesitancy in using COVID 19 prevention behaviors among African
Americans: Strategies to
build confidence
42. New strategies for psychological well-being at work
43. Mitigating mental health changes with virtual reality technology during
Covid-19: A narrative
44. Music therapy for patients with neurological disorders during COVID-19
pandemic
45. Mental health and the modulating effects of receiving the COVID-19
vaccination
46. Personalized cognitive behavioral therapy on patients with obesity in
COVID-19 pandemic
47. Social anxiety disorder and Covid 19: Treatment with cognitive
behavioral therapy
48. Burnout during the COVID-19 pandemic: Modulating role of mindfulness
Section E: Case studies with mini review
49. Case study: Evaluation of a long Covid assessment service (LCAS)
50. Case study: Navigating youth mental health and addictions care in the
context of the COVID-19 pandemic
51. Case study: Restless leg syndrome associated with COVID-19
Section F: Resources
52. Recommended resources for linking neuroscience and behavior in
coronavirus disease
(COVID-19)